Inventor · disambiguated record
Robert F. Dunn
Also filed as: DUNN ROBERT · DUNN ROBERT F · DUNN ROBERT FRANCIS
19 granted patents·17 pending applications·136 citations·filing 2003–2022
94Inventor score
Top patents by PatentIndex Score
36 records- 0196US11124478B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2020·Granted Sep 21, 2021·5 cites·5 claims
- 0295US11767292B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Sep 26, 2023·3 cites·12 claims
- 0395US11708371B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Jul 25, 2023·3 cites·13 claims
- 0495US10899771B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2019·Granted Jan 26, 2021·7 cites·4 claims
- 0595US10577316B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2017·Granted Mar 3, 2020·9 cites·23 claims
- 0694US9822121B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2016·Granted Nov 21, 2017·13 cites·12 claims
- 0794US9809536B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2012·Granted Nov 7, 2017·12 cites·19 claims
- 0893US10435410B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2018·Granted Oct 8, 2019·9 cites·16 claims
- 0993US10087189B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2017·Granted Oct 2, 2018·10 cites·10 claims
- 1092US7696229B2Compounds having 5-HT6 receptor affinityMEMORY PHARM CORP·Filed 2007·Granted Apr 13, 2010·22 cites·30 claims
- 1186US7226930B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Jun 5, 2007·27 cites·37 claims
- 1275US7723348B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2008·Granted May 25, 2010·2 cites·61 claims
- 1375US7585882B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Sep 8, 2009·2 cites·35 claims
- 1475US7495017B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2007·Granted Feb 24, 2009·2 cites·45 claims
- 1571US9187488B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsZACUTO MICHAEL J·Filed 2012·Granted Nov 17, 2015·3 cites·10 claims
- 1671US7432266B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Oct 7, 2008·1 cites·57 claims
- 1770US7405230B2Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogsMEMORY PHARM CORP·Filed 2003·Granted Jul 29, 2008·5 cites·39 claims
- 1861US7696198B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 13, 2010·1 cites·17 claims
- 1960US2015087832A1Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 2057US2009118270A1Phosphodiesterase 4 inhibitorsTALAMAS FRANCISCO XAVIER·Filed 2008·Application pending·0 cites
- 2156US2009221661A1Phosphodiesterase 4 inhibitorsHOPPER ALLEN·Filed 2009·Application pending·0 cites
- 2254US2009306156A1Phosphodiesterase 4 inhibitorsHOPPER ALLEN·Filed 2009·Application pending·0 cites
- 2352US9527855B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 27, 2016·0 cites·4 claims
- 2452US2010029689A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 2552US2010022581A1Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 2652US2010056531A1Alkyl-substituted 3' compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 2751US2010029629A1Acyclic compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 2851US2007049611A1Phosphodiesterase 4 inhibitorsTALAMAS FRANCISCO X·Filed 2006·Application pending·0 cites
- 2950US2009069337A13' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 3050US2009048255A1Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogsSCHUMACHER RICHARD A·Filed 2008·Application pending·0 cites
- 3149US2007254913A1Phosphodiesterase 4 inhibitorsDUNN ROBERT F·Filed 2007·Application pending·0 cites
- 3249US2008318941A14' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 3349US2008200471A16' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 3447US2024228475A1Processes for the preparation of (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2022·Application pending·0 cites
- 3546US2005222207A1Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogsSCHUMACHER RICHARD·Filed 2004·Application pending·0 cites
- 3643US2010152177A1Compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →